2020
Multi-Component Regenerative Research
Various authors
Research interest in component combinations spans tissue repair, vascular remodeling, and inflammation modulation.
Lot CBR-KLW-260411-001✓ Verified
About KLOW
KLOW is a multi-peptide blend combining GHK-Cu, BPC-157, TB-500 fragment, and KPV in a single 80 mg lyophilized formulation. The blend is supplied for comprehensive regenerative-research applications where multi-component intervention is part of the study design.
Component peptides are individually tested for identity and purity before blending; the final product is independently verified for aggregate purity and endotoxin content per batch.
Each component peptide is documented in its own monograph in the COA Library for reference.
Identity & Specifications
Sequence
GHK-Cu · BPC-157 · TB-500 · KPV
Length
4-component blend
Formula
Multi-component
Mol. weight
Aggregate
CAS
N/A
PubChem
N/A
Purity (HPLC)
99.7%
Endotoxin (USP <85>)
32.5 EU/vial · PASS
Certificate of Analysis
Lot CBR-KLW-260411-001 — purity, potency, and bacterial endotoxin independently verified by BTLabs (West Palm Beach, FL).
| Parameter | Method | Spec | Result |
|---|---|---|---|
| Identity | FTIR (USP <197A>) | Confirms blend | Conforms |
| Appearance | Visual (USP <630>) | Purple powder | Purple powder |
| Purity (overall) | HPLC-UV 220 nm (USP <621>) | ≥ 98.0% | 99.7% |
| Potency — GHK-Cu | HPLC-UV 220 nm | — | 53.1 mg (66.4%) |
| Potency — KPV | HPLC-UV 220 nm | — | 11.6 mg (14.5%) |
| Potency — TB-500 | HPLC-UV 220 nm | — | 8.7 mg (10.9%) |
| Potency — BPC-157 | HPLC-UV 220 nm | — | 8.4 mg (10.5%) |
| Bacterial Endotoxin | Gel-clot (USP <85>) | < 40 EU/vial | 32.5 EU/vial · PASS |
KLOW is a four-component blend of GHK-Cu, BPC-157, TB-500 fragment, and KPV totaling 80 mg active. Component proportions appear on the signed certificate; the blend ratio is intentional and consistent across lots.
Download signed certificate →Download Safety Data Sheet →Signed Certificate of Analysis
Independent third-party laboratory: BTLabs · 5730 Corporate Way, Suite 220, West Palm Beach, FL 33407 · (561) 625-0133. Three signed pages reproduced below verbatim. Open the original PDF →
Selected References
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways. Biomed Res Int, 2015.
- Sikiric P, et al. Stable gastric pentadecapeptide BPC-157. Curr Pharm Des, 2014.
- Crockford D, et al. Thymosin beta-4: structure, function, and biological properties. Ann NY Acad Sci, 2010.
- Lipton JM, Catania A. α-MSH peptides for inflammation. Ann NY Acad Sci, 1998.
Recent Research Highlights
2015
GHK-Cu Component
Pickart et al.
See GHK-Cu monograph for component-specific literature.
2014
BPC-157 Component
Sikiric et al.
See BPC-157 monograph for component-specific literature.
2010
TB-500 / KPV Components
Goldstein, Lipton et al.
See respective monographs for component-specific literature.
⊕
3rd Party Tested
Independent lab
≥98%
HPLC Purity
+ ESI-MS
LAL
Endotoxin
LAL kinetic
§
Lot-traceable
In COA library
§ Research-Use Compliance
Laboratory research chemical / reagent — not a supplement or drug.
This compound is supplied by Crescent Bioresearch LLC for laboratory research and pre-clinical use only. It is not a drug, dietary supplement, food, or cosmetic, and has not been approved by the U.S. Food and Drug Administration for human or veterinary administration, diagnosis, treatment, or prevention of any condition.
The pharmacological, toxicological, and stability properties of this compound have not been fully studied. It must therefore be handled only by personnel trained in laboratory safety practices.
The purchaser bears sole responsibility for ensuring that all handling, storage, and intended use comply with applicable local, state, and federal regulations. Full terms are set out in the RUO Disclaimer and Terms of Service.
